AMEX
6.35USD
+0.07 (+1.11%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
79.2M
P/E
—
EPS
—
Beta
1.47
52W range
2.21-9.33
Day range
6.35–6.46
Open
6.46
Prev close
6.28
Volume
27.7K
Avg volume
127.1K
Dividend
0.00
IPO
2023-08-09
https://www.zacks.com/stock/news/2975155/nrxs-stock-dips-post-q2-earnings-despite-revenue-surge-gross-margin-up?cid=CS-STOCKNEWSAPI-FT-microcap_article|earnings-2975155 · 8/14/2026-0.40
https://www.defenseworld.net/2025/12/25/neuraxis-nasdaqnrxs-stock-price-up-9-6-heres-why.html · 12/25/2025+0.60
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
